Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Dendreon FDA Deadline Set For May 1
|
Luke Timmerman |
11/20/09 |
Seattle
|
|
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/12/09 |
Seattle
|
|
BioVex Nails Down Another $30M To Finish Pivotal Study of Cancer-Killing Virus
|
Luke Timmerman |
11/10/09 |
Boston
|
|
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer
|
Luke Timmerman |
11/10/09 |
Boston
|
|
Dendreon Burns $28M in Q3
|
Luke Timmerman |
11/09/09 |
Seattle
|
|
Dendreon Files FDA Application, DxBox Reaches Turning Point, ISB to Do 100 Genomes, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/05/09 |
Seattle
|
|
Dendreon Files Provenge Application to FDA Ahead of Schedule, Now It’s Time to Wait
|
Luke Timmerman |
11/02/09 |
Seattle
|
|
Sequel Pharmaceuticals’ CEO on How to Start a Biotech and Sell it For a Bundle, and Repeat
|
Luke Timmerman |
10/28/09 |
San Diego
|
|
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
Five Red Flags to Watch Out For in a Biotech, From Dendreon Co-Founder Chris Henney
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney
|
Luke Timmerman |
10/14/09 |
Seattle
|
|
Dendreon Recruits Genentech CEO, Former Lilly Manufacturing Chief to Board
|
Luke Timmerman |
10/09/09 |
Seattle
|
|
How Much Do Biotech Workers Really Earn? Maybe Not as Much as Politicians Say
|
Luke Timmerman |
10/02/09 |
Seattle
|
|
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/01/09 |
Seattle
|
|
Lee Hood’s New Idea, Calypso Scores $50M, Novo’s Historic Mistake Pays Off for Seattle, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/25/09 |
Seattle
|
|
Dendreon to Turn in Provenge Application to FDA in Mid-November
|
Luke Timmerman |
09/24/09 |
Seattle
|
|
Five Big Questions For Dendreon’s Analyst Day
|
Luke Timmerman |
09/24/09 |
Seattle
|
|
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009
|
Luke Timmerman |
09/22/09 |
Seattle
|
|
Cell Therapeutics Nabs $30M, Rick Klausner on Vaccines, Targeted Growth Tinkers With Algae Genes, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/13/09 |
Seattle
|
|
Dendreon Ends June with $287M Cash
|
Luke Timmerman |
08/11/09 |
Seattle
|
|
Dendreon Will Build Manufacturing Plant in Georgia
|
Eric Hal Schwartz |
08/10/09 |
Seattle
|
|
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/06/09 |
Seattle
|
|
OncoGenex, Toiling in Dendreon’s Shadow, Scopes Out Partners For Prostate Cancer Drug
|
Luke Timmerman |
08/05/09 |
Seattle
|
|
AVI Biopharma Bolts from Portland to Seattle to Tap Biotech Talent
|
Luke Timmerman |
07/30/09 |
Seattle
|
|
Dendreon’s Former Boss Predicts Takeover, Covance Buys Merck Lab, How NanoString Got $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/30/09 |
Seattle
|
|
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 2
|
Luke Timmerman |
07/28/09 |
Seattle
|
|
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 1
|
Luke Timmerman |
07/27/09 |
Seattle
|
|
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/23/09 |
Seattle
|
|
Dendreon Scouts for Next Manufacturing Plant, Probably Far From Salmon and Evergreens
|
Luke Timmerman |
07/22/09 |
Seattle
|
|
Page 1 of
4 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
